Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2017

Open Access 01-12-2017 | Research article

Assessment of the length of sick leave in patients with ischemic heart disease

Authors: Nausica Català Tella, Catalina Serna Arnaiz, Jordi Real Gatius, Oriol Yuguero Torres, Leonardo Galván Santiago

Published in: BMC Cardiovascular Disorders | Issue 1/2017

Login to get access

Abstract

Background

The prevalence of ischemic heart disease is high. Few recent studies have investigated the periods of sick leave of these patients. Our aim is to determine the length of sick leave after an acute coronary syndrome, its costs, associated factors and to assess the use of antidepressants and/or anxiolytics.

Methods

An observational study of a retrospective cohort of patients on sick leave due to ischemic heart disease in a health region between 2008–2011, with follow-up until the first return to work, death, or end of the study (31/12/2012). Measurements: length of sick leave, sociodemographic variables and medical prescriptions.

Results

Four hundred and ninety-seven patients (mean age 53 years, 90.7% male), diagnosed with acute myocardial infarction (60%), angina pectoris (20.7%) or chronic form of ischemic heart disease (19.1%). Thirty-seven per cent of patients took anxiolytics the year after diagnosis and 15% took antidepressants. The average duration of sick leave was 177 days (95% CI: 163–191 days). Patients diagnosed with acute myocardial infarction returned to work after a mean of 192 days, compared to 128 days in cases with angina pectoris. Patients who took antidepressants during the year after diagnosis returned to work after a mean of 240 days. The mean work productivity loss was estimated to be 9,673 euros/person.

Conclusions

The mean duration of sick leave due to ischemic heart disease was almost six months. Consumption of psychotropic medication doubled after the event. Older age, suffering an acute myocardial infarction and taking antidepressants were associated with a longer sick leave period.
Literature
1.
go back to reference Baena JM, del Val JL, Tomàs J, Martínez JL, Martín R, González I, et al. Epidemiología de las enfermedades cardiovasculares y factores de riesgo en atención primaria. Rev Esp Cardiol. 2005;58:367–73.CrossRef Baena JM, del Val JL, Tomàs J, Martínez JL, Martín R, González I, et al. Epidemiología de las enfermedades cardiovasculares y factores de riesgo en atención primaria. Rev Esp Cardiol. 2005;58:367–73.CrossRef
2.
go back to reference López J, Rodríguez A, Fernández S. Cardiopatía isquémica. AMF: Actualización en Medicina de Familia. 2011;7(6):304–15. López J, Rodríguez A, Fernández S. Cardiopatía isquémica. AMF: Actualización en Medicina de Familia. 2011;7(6):304–15.
3.
go back to reference Nichols M, Townsend N, Scarborough P, Rayneret M. European cardiovascular disease statistics 2012. Sophia antipolis: European Heart Network, Brussels, European Society of Cardiology, Sophia Antipolis; 2012:104. Nichols M, Townsend N, Scarborough P, Rayneret M. European cardiovascular disease statistics 2012. Sophia antipolis: European Heart Network, Brussels, European Society of Cardiology, Sophia Antipolis; 2012:104.
4.
go back to reference Fernández J, López SE. Carga económica y social de la enfermedad coronaria. Rev Esp Cardiol Supl. 2013;13(B):42–7. Fernández J, López SE. Carga económica y social de la enfermedad coronaria. Rev Esp Cardiol Supl. 2013;13(B):42–7.
5.
go back to reference Sicras A, Fernández J, Navarro R, Martín I, Varela C. Morbimortalidad y consumo de recursos asociados tras síndrome coronario agudo en una población española. Revista clínica española. 2011;211(11):560–71.CrossRef Sicras A, Fernández J, Navarro R, Martín I, Varela C. Morbimortalidad y consumo de recursos asociados tras síndrome coronario agudo en una población española. Revista clínica española. 2011;211(11):560–71.CrossRef
6.
go back to reference Oliva J, Lobo F, López J, Duque B, Osuna R. Costes no sanitarios ocasionados por las enfermedades isquémicas del corazón en España. 2004. España: Ministerio de Industria, Comercio y Turismo. Oliva J, Lobo F, López J, Duque B, Osuna R. Costes no sanitarios ocasionados por las enfermedades isquémicas del corazón en España. 2004. España: Ministerio de Industria, Comercio y Turismo.
8.
go back to reference Jiménez M, Mata C, Bascuas J, Abad E, García AI, E. Reincorporación laboral del trabajador coronario: criterios objetivos para un cambio de puesto de trabajo. Trauma. 2008;19(3):165–70. Jiménez M, Mata C, Bascuas J, Abad E, García AI, E. Reincorporación laboral del trabajador coronario: criterios objetivos para un cambio de puesto de trabajo. Trauma. 2008;19(3):165–70.
9.
go back to reference Gutiérrez J, Vacas M, Lobato A, Llorca J, Prieto JA, Domenech J, et al. Impacto del infarto de miocardio en la situación laboral de los pacientes. Rev Esp Cardiol. 1999;52:556–62.CrossRef Gutiérrez J, Vacas M, Lobato A, Llorca J, Prieto JA, Domenech J, et al. Impacto del infarto de miocardio en la situación laboral de los pacientes. Rev Esp Cardiol. 1999;52:556–62.CrossRef
11.
go back to reference Perk J, Alexanderson K. Sick leave due to coronary artery disease or stroke. Scand J Public Health. 2004;32(63 suppl):181–206.CrossRef Perk J, Alexanderson K. Sick leave due to coronary artery disease or stroke. Scand J Public Health. 2004;32(63 suppl):181–206.CrossRef
13.
go back to reference Ferreira I. Epidemiología de la enfermedad coronaria. Rev EspCardiol. 2014;67(2):139–44. Ferreira I. Epidemiología de la enfermedad coronaria. Rev EspCardiol. 2014;67(2):139–44.
14.
go back to reference Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Executive summary: heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127:143–52.CrossRefPubMed Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Executive summary: heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127:143–52.CrossRefPubMed
16.
go back to reference Lerner D, Kannel W. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 1986;111:383–90.CrossRefPubMed Lerner D, Kannel W. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 1986;111:383–90.CrossRefPubMed
17.
go back to reference Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med. 1978;89:157–61.CrossRefPubMed Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med. 1978;89:157–61.CrossRefPubMed
18.
go back to reference Andrée M, Duran X, Alonso J, Martínez JM, Espallargues M, Benavides FG. Estimación de la carga de enfermedad por incapacidad laboral permanente en España durante el período 2009–2012. Rev Esp Salud Pública. 2014;88:349–58.CrossRef Andrée M, Duran X, Alonso J, Martínez JM, Espallargues M, Benavides FG. Estimación de la carga de enfermedad por incapacidad laboral permanente en España durante el período 2009–2012. Rev Esp Salud Pública. 2014;88:349–58.CrossRef
19.
go back to reference Janzon M, Levin LA, Swahn E. Cost-effectiveness of an invasive strategy in unstable coronary artery disease: results from the FRISC II invasive trial. The Fast Revascularisation during InStability in Coronary artery disease. Eur Heart J. 2002;23(1):31–40.CrossRefPubMed Janzon M, Levin LA, Swahn E. Cost-effectiveness of an invasive strategy in unstable coronary artery disease: results from the FRISC II invasive trial. The Fast Revascularisation during InStability in Coronary artery disease. Eur Heart J. 2002;23(1):31–40.CrossRefPubMed
20.
go back to reference Shanfield SB. Return to work after an acute myocardial infarction: a review. Heart Lung. 1990;19(2):109–17.PubMed Shanfield SB. Return to work after an acute myocardial infarction: a review. Heart Lung. 1990;19(2):109–17.PubMed
21.
go back to reference Alegria-Ezquerra E, Grima A. Reporting on coronary patients for return to work: an algorithm. e-journal of the ESC Council for Cardiology Practice. 2012; 10(20–23). Alegria-Ezquerra E, Grima A. Reporting on coronary patients for return to work: an algorithm. e-journal of the ESC Council for Cardiology Practice. 2012; 10(20–23).
22.
go back to reference Mittag O, Schramm S, Böhmen S, Hüppe A, Meyer T, Raspe H. Medium-term effects of cardiac rehabilitation in Germany: systematic review and meta analysis of results from national and international trials. Eur J Cardiovasc Prev Rehabil. 2011;18:587–93.CrossRefPubMed Mittag O, Schramm S, Böhmen S, Hüppe A, Meyer T, Raspe H. Medium-term effects of cardiac rehabilitation in Germany: systematic review and meta analysis of results from national and international trials. Eur J Cardiovasc Prev Rehabil. 2011;18:587–93.CrossRefPubMed
23.
go back to reference Mirmohammadi SJ, Sadr-Bafghi SM, Mehrparvar AH, Gharavi M, Davari MH, Bahaloo M, et al. Evaluation of the return to work and its duration after myocardial infarction. ARYA Atheroscler. 2014;10(3):137.PubMedPubMedCentral Mirmohammadi SJ, Sadr-Bafghi SM, Mehrparvar AH, Gharavi M, Davari MH, Bahaloo M, et al. Evaluation of the return to work and its duration after myocardial infarction. ARYA Atheroscler. 2014;10(3):137.PubMedPubMedCentral
24.
go back to reference Boudrez H, De Backer G. Recent findings on return to work after an acute myocardial infarction or coronary artery bypass grafting. Acta Cardiol. 2000;55:341–9.CrossRefPubMed Boudrez H, De Backer G. Recent findings on return to work after an acute myocardial infarction or coronary artery bypass grafting. Acta Cardiol. 2000;55:341–9.CrossRefPubMed
25.
go back to reference Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI Guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011;58:44–122.CrossRef Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI Guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011;58:44–122.CrossRef
26.
go back to reference Kronish IM, Krupka DJ, Davidson KW. How should we treat depression in patients with cardiovascular disease? Dialogues Cardiovasc Med. 2012;17(2):126–33. Kronish IM, Krupka DJ, Davidson KW. How should we treat depression in patients with cardiovascular disease? Dialogues Cardiovasc Med. 2012;17(2):126–33.
27.
go back to reference Nabi H, Shipley MJ, Vahtera J, Hall M, Korkeila J, Marmot MG, Kivimäki M, et al. Effects of depressive symptoms and coronary heart disease and their interactive associations on mortality in middle-aged adults: the Whitehall II cohort study. Heart. 2010;96(20):1645–50.CrossRefPubMedPubMedCentral Nabi H, Shipley MJ, Vahtera J, Hall M, Korkeila J, Marmot MG, Kivimäki M, et al. Effects of depressive symptoms and coronary heart disease and their interactive associations on mortality in middle-aged adults: the Whitehall II cohort study. Heart. 2010;96(20):1645–50.CrossRefPubMedPubMedCentral
28.
go back to reference Lichtman JH, Bigger JT, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lespérance F, et al. Depression and coronary heart disease recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation. 2008;118(17):1768–75.CrossRefPubMed Lichtman JH, Bigger JT, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lespérance F, et al. Depression and coronary heart disease recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation. 2008;118(17):1768–75.CrossRefPubMed
29.
go back to reference Pozuelo L, Tesar G, Zhang J, Penn M, Franco K, Jiang W. Depression and heart disease: what do we know, and where are we headed? Cleve Clin J Med. 2009;76(1):59–70.CrossRefPubMed Pozuelo L, Tesar G, Zhang J, Penn M, Franco K, Jiang W. Depression and heart disease: what do we know, and where are we headed? Cleve Clin J Med. 2009;76(1):59–70.CrossRefPubMed
Metadata
Title
Assessment of the length of sick leave in patients with ischemic heart disease
Authors
Nausica Català Tella
Catalina Serna Arnaiz
Jordi Real Gatius
Oriol Yuguero Torres
Leonardo Galván Santiago
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2017
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-016-0460-7

Other articles of this Issue 1/2017

BMC Cardiovascular Disorders 1/2017 Go to the issue